Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Monday, January 13, 2025, at 11:15 a.m. Eastern Time.
The presentation will be available through a live webcast, with replay access remaining available for two weeks afterward in the Event Archive section of Inspire's Investor website at investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), un'azienda tecnologica nel settore medico specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, ha annunciato la sua partecipazione al 43° Annual J.P. Morgan Healthcare Conference. Il team di gestione dell'azienda presenterà il lunedì 13 gennaio 2025, alle 11:15 ora orientale.
La presentazione sarà disponibile attraverso un -webinar in diretta, con accesso alla registrazione disponibile per due settimane dopo nella sezione Archivio Eventi del sito web per gli investitori di Inspire all'indirizzo investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), una empresa de tecnología médica especializada en soluciones mínimamente invasivas para la apnea obstructiva del sueño, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. El equipo de gestión de la empresa está programado para presentar el lunes 13 de enero de 2025, a las 11:15 a.m. hora del este.
La presentación estará disponible a través de un webcast en vivo, con acceso a la repetición disponible por dos semanas después en la sección Archivo de Eventos del sitio web para inversores de Inspire en investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP)는 이식 최소 침습적 수면 무호흡 솔루션을 전문으로 하는 의료 기술 회사로, 제43회 연례 J.P. Morgan Healthcare 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2025년 1월 13일 월요일, 동부 표준시 기준 오전 11시 15분에 발표할 예정입니다.
발표는 실시간 웹캐스트를 통해 제공되며, 발표 후 2주 동안 Inspire의 투자자 웹사이트의 이벤트 아카이브 섹션에서 재생 접근이 가능합니다: investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), une entreprise de technologie médicale spécialisée dans des solutions peu invasives pour l'apnée du sommeil obstructive, a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de la société est prévue pour présenter le lundi 13 janvier 2025, à 11h15 heure de l'Est.
La présentation sera disponible via un webdiffusion en direct, avec un accès à la rediffusion disponible pendant deux semaines par la suite dans la section Archive des Événements sur le site des investisseurs d'Inspire à l'adresse investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), ein Medizintechnikunternehmen, das sich auf minimalinvasive Lösungen für obstruktive Schlafapnoe spezialisiert hat, hat seine Teilnahme an der 43. Jahreskonferenz von J.P. Morgan Healthcare angekündigt. Das Management-Team des Unternehmens wird am Montag, den 13. Januar 2025, um 11:15 Uhr Eastern Time präsentieren.
Die Präsentation wird über einen Live-Webcast verfügbar sein, mit einem Zugriff auf die Wiederholung, der zwei Wochen lang im Event-Archiv-Bereich der Investorenseite von Inspire unter investors.inspiresleep.com verfügbar bleibt.
- None.
- None.
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.
Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When is Inspire Medical Systems (INSP) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch Inspire Medical Systems' (INSP) J.P. Morgan Healthcare Conference presentation?
What is the focus of Inspire Medical Systems' (INSP) healthcare technology?
How long will the INSP presentation replay be available after the J.P. Morgan Healthcare Conference?
